Search results
Janie Slaven: TONI SAYS: Why is Medicare Part D's IRMAA premium so high?
The Times-Tribune, Corbin, Ky. via Yahoo News· 3 hours agoApr. 19—Dear Toni: I am turning 65 in June, self-employed, and my income together with my wife's is over $300,000. Recently I received a letter from Social Security telling me that my monthly ...
Opinion: CT prescription drug bill would hurt patients, not help them
CT Mirror· 5 days agoDrug Affordability, which includes policy proposals to establish a Prescription Drug Affordability...
How Wake County will spend millions of dollars in opioid settlement money
Raleigh News and Observer via AOL· 5 hours ago“In Wake County, there are some really strong programs, but not everyone has access, particularly...
Auxiliary deputy with felony convictions added to security detail for Biden visit
NBC Washington· 21 hours agoThe White House executive visit to Germanna Community College on Feb. 10, 2022, was a chance for...
UCLA Benefits Handsomely From Xtandi Cancer Drug Royalties Amid Controversy Over Drug Pricing
Los Angeles Magazine· 1 day agoUCLA, reaping billions from the cancer drug Xtandi developed with public funds, opposes U.S. plans...
HHS-OIG Highlights Anti-Fraud Safeguards for Patient Assistance Programs Backed Mainly By Drug...
The National Law Review· 2 hours agoHighlights The HHS-OIG released a favorable opinion regarding rare-disease patient assistance...
JD Supra: Déjà Vu: Biden’s 2025 Budget Nearly Identical on Health, Retirement
JD Supra· 1 day agoOn March 11, 2024, President Biden released his budget for Fiscal Year 2025. Although most of these proposals are unlikely to be considered or become law in this Congress with Republicans holding ...
We’re paying off medical debt wrong
The Hill· 39 minutes agoMedical debt imposes a crushing burden on millions of Americans. More than 40 percent of Americans owe medical debt, with 18 percent owing $2,500 or...
HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates
The National Law Review· 4 days ago...reductions or other remuneration offered by a pharmaceutical manufacturer to a Medicare Part D plan sponsor (“Plan Sponsor”), a Medicaid managed care organization (“MCO”), and/or a pharmacy benefit manager (“...Union address on February 5, 2019 – is one of the most significant healthcare...
Oklahoma Is the Place to Be . . . Especially for Value-Based Contracting
The National Law Review· 3 days agoOn May 11, 2018, President Trump released the American Patients First Blueprint, a plan to lower drug prices and reduce beneficiary out-of-pocket spending ...
